Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
RESEARCH TOOLSreports
Total Valuation
BioStem Technologies has a market cap or net worth of $163.38M. The enterprise value is $145.11M.
Market Cap$163.38M
Enterprise Value$145.11M
Share Statistics
BioStem Technologies has 16,338,436 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,338,436
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioStem Technologies’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 71.51%.
Return on Equity (ROE)0.78
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)71.51%
Return on Capital Employed (ROCE)0.75
Revenue Per Employee150.91M
Profits Per Employee15.94M
Employee Count2
Asset Turnover2.15
Inventory Turnover7.66
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio7.1
PS Ratio0.00
PB Ratio4.10
Price to Fair Value5.54
Price to FCF6.92
Price to Operating Cash Flow6.84
PEG Ratio0.04
Income Statement
In the last 12 months, BioStem Technologies had revenue of 301.83M and earned 31.88M in profits. Earnings per share was 1.95.
Revenue301.83M
Gross Profit287.86M
Operating Income31.20M
Pretax Income30.61M
Net Income31.88M
EBITDA31.49M
Earnings Per Share (EPS)1.95
Cash Flow
In the last 12 months, operating cash flow was 24.48M and capital expenditures -426.56K, giving a free cash flow of 24.05M billion.
Operating Cash Flow24.48M
Free Cash Flow24.05M
Free Cash Flow per Share1.47
Dividends & Yields
BioStem Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.81
52-Week Price Change9.42%
50-Day Moving Average12.80
200-Day Moving Average13.46
Relative Strength Index (RSI)33.11
Average Volume (3m)53.20K
Important Dates
BioStem Technologies upcoming earnings date is Aug 26, 2025, During Market Hours (Confirmed).
Last Earnings DateMay 12, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
BioStem Technologies as a current ratio of 1.35, with Debt / Equity ratio of 10.75%
Current Ratio1.35
Quick Ratio1.33
Debt to Market Cap0.02
Net Debt to EBITDA-0.59
Interest Coverage Ratio53.13
Taxes
In the past 12 months, BioStem Technologies has paid -1.27M in taxes.
Income Tax-1.27M
Effective Tax Rate-0.04
Enterprise Valuation
BioStem Technologies EV to EBITDA ratio is 6.61, with an EV/FCF ratio of 8.65.
EV to Sales0.69
EV to EBITDA6.61
EV to Free Cash Flow8.65
EV to Operating Cash Flow8.50
Balance Sheet
BioStem Technologies has $22.83M in cash and marketable securities with $4.39M in debt, giving a net cash position of -$18.44M billion.
Cash & Marketable Securities$22.83M
Total Debt$4.39M
Net Cash-$18.44M
Net Cash Per Share-$1.13
Tangible Book Value Per Share$2.47
Margins
Gross margin is 95.39%, with operating margin of 10.34%, and net profit margin of 10.56%.
Gross Margin95.39%
Operating Margin10.34%
Pretax Margin10.14%
Net Profit Margin10.56%
EBITDA Margin10.43%
EBIT Margin10.34%
Analyst Forecast
The average price target for BioStem Technologies is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$15.00
Price Target Upside43.54% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast473.06%
EPS Growth Forecast―